Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

0.3301 +0.0166 (+5.30%)
Delayed Quote Updated: 1:10 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 818,260
Open 0.3151
Bid (Size) 0.3301 (100)
Ask (Size) 0.3320 (3,200)
Prev. Close 0.3135
Today's Range 0.3129 - 0.3350
52wk Range 0.2610 - 1.575
Shares Outstanding 140,759,276
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's after hours session ↗
Via Chartmill
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill

Performance

YTD
-73.8%
-73.8%
1 Month
+3.8%
+3.8%
3 Month
-22.2%
-22.2%
6 Month
-58.9%
-58.9%
1 Year
-73.8%
-73.8%

More News

Read More
News headline image
Heron (HRTX) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
Heron Therapeutics Q1 Results Miss, but Acute Care Growth and Reaffirmed Outlook Support HRTX ↗
Via Chartmill
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Q4 2025 Revenue Beat and Positive 2026 Outlook ↗
Via Chartmill
News headline image
Heron Therapeutics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
Heron Therapeutics Announces Second Quarter 2026 Financial Results
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
U.S. District Court Issues Decision Regarding CINVANTI® Patents
From Heron Therapeutics, Inc.
Via GlobeNewswire
Which stocks are moving after the closing bell on Monday? ↗
Via Chartmill
News headline image
Heron (HRTX) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Supply Chain
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Heron Therapeutics Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron (HRTX) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)
From Heron Therapeutics, Inc.
Via GlobeNewswire
News headline image
Heron Therapeutics Inc (NASDAQ:HRTX) Reports Mixed Q3 2025 Results, Misses Revenue and Earnings Estimates ↗
Via Chartmill

Frequently Asked Questions

Is Heron Therapeutics, Inc. - Common Stock publicly traded?
Yes, Heron Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Heron Therapeutics, Inc. - Common Stock trade on?
Heron Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heron Therapeutics, Inc. - Common Stock?
The ticker symbol for Heron Therapeutics, Inc. - Common Stock is HRTX on the Nasdaq Stock Market
What is the current price of Heron Therapeutics, Inc. - Common Stock?
The current price of Heron Therapeutics, Inc. - Common Stock is 0.3301
When was Heron Therapeutics, Inc. - Common Stock last traded?
The last trade of Heron Therapeutics, Inc. - Common Stock was at 10/01/26 01:10 PM ET
What is the market capitalization of Heron Therapeutics, Inc. - Common Stock?
The market capitalization of Heron Therapeutics, Inc. - Common Stock is 46.46M
How many shares of Heron Therapeutics, Inc. - Common Stock are outstanding?
Heron Therapeutics, Inc. - Common Stock has 46M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.